Core Insights - The recent technology appraisal meeting organized by Shandong Light Industry Association recognized two significant scientific achievements from Furuida Biopharmaceuticals, marking them as "internationally leading" and "internationally advanced" in the fields of functional skin microbiome and zinc hyaluronate research [1][7]. Group 1: Research Achievements - The project on "Preparation of Zinc Hyaluronate and Its Application in Skincare Products" has successfully overcome technical bottlenecks over a five-year research period, establishing the first domestic detection standard and demonstrating effective targeting of 5α-reductase [3]. - The project has resulted in the publication of 2 scientific papers and the granting of 3 invention patents, filling a research gap in the precise oil control and soothing skincare direction for zinc hyaluronate derivatives [3]. Group 2: Functional Skin Microbiome Research - The project "Research on Functional Skin Microbiome and Development of Functional Care Products" has created a correlation database linking skin microbiome distribution to physiological parameters across different populations, establishing a functional skin microbiome screening platform [5]. - This project has led to the application for 10 invention patents, with 4 granted, and the publication of 7 scientific papers, including 5 in SCI journals, thereby setting a standard in the field of microbiome science in skincare [5]. Group 3: Future Directions - Furuida Biopharmaceuticals aims to continue its deep exploration in the fields of zinc hyaluronate and skin microbiome, establishing itself as a benchmark in the hyaluronate industry and leading the scientific skincare sector [9].